TERUMO CORP revenue for the last year amounted to 100.94 B MXN, the most of which — 60.85 B MXN — came from its highest performing source at the moment, Cardiovascular, the year earlier bringing 65.25 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought TERUMO CORP 30.65 B MXN, and the year before that — 33.42 B MXN.